New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 7, 2014
07:15 EDTATHNathenahealth price target lowered to $90 from $120 at Oppenheimer
Oppenheimer reduced its price target on athenahealth after the stock dropped following David Einhorn's pessimistic presentation about it. Oppenheimer believes that the company's margins are "structurally disadvantaged" versus those of pure software as a service companies. The firm keeps an Underperform rating on the stock.
News For ATHN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 21, 2014
12:08 EDTATHNEinhorn says athenahealth 'doesn't earn any money'
Subscribe for More Information
12:06 EDTATHNEinhorn says short thesis on athenahealth 'working itself out'
Subscribe for More Information
October 20, 2014
06:38 EDTATHNathenahealth price target lowered to $115 from $140 at RBC Capital
Subscribe for More Information
October 17, 2014
09:17 EDTATHNOn The Fly: Pre-market Movers
Subscribe for More Information
08:05 EDTATHNathenahealth reports Q3 adjusted EPS 27c, consensus 27c
athenahealth last night reported Q3 revenue $190.4M, consensus $190.4M. The company reported it grew net new active physicians on athenaCollector, which had 3,420 physicians added, athenaClinicals, which had 2,786 physicians added, and athenaCommunicator, which had 3,846 physicians added, for the three months ended September 30.
October 16, 2014
18:36 EDTATHNOn The Fly: After Hours Movers
Subscribe for More Information
16:07 EDTATHNathenahealth now sees FY14 EPS near high end of range
athenahealth said, "We are not making any changes to the fiscal year 2014 guidance...However, based on our year-to-date performance and current expectations for Q4 2014, we are providing additional insight into our fiscal year 2014 guidance as follows: "We expect GAAP Total Revenue to be at or above the mid-point of the $725M-$755M guidance range. We expect Non-GAAP Adjusted Gross Margin to be close to the mid-point of the 62.5% to 63.5% guidance range. We expect Non-GAAP Adjusted Net Income per Diluted share to be close to the high end of the 98c-$1.10 guidance range."
16:05 EDTATHNathenahealth sees FY14 adjusted EPS 98c-$1.10, consensus $1.09
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use